Loading…
Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression
Background: Controverted results have been obtained using high frequency transcranial magnetic stimulation (HF-rTMS) as an antidepressant treatment. Method: Forty patients suffering from drug-resistant major depression received ten sessions of HF-rTMS at 90% of the motor threshold on the left prefro...
Saved in:
Published in: | Journal of affective disorders 2001-05, Vol.64 (2), p.271-275 |
---|---|
Main Authors: | , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Background: Controverted results have been obtained using high frequency transcranial magnetic stimulation (HF-rTMS) as an antidepressant treatment.
Method: Forty patients suffering from drug-resistant major depression received ten sessions of HF-rTMS at 90% of the motor threshold on the left prefrontal cortex or sham stimulation, added to their pharmacological treatment, in a randomized double-blind design. In a second open phase, patients still fulfilling criteria of inclusion received ten additional sessions of HF-rTMS at 90 or 110%.
Results: Real, but not sham HF-rTMS, was associated with a significant decrease in the Hamilton Depression Rating Scale, but only twelve patients decreased more than 50%.
Conclusions: Left prefrontal HF-rTMS was effectively associated with antidepressant treatment, although the size effect was small.
Limitations: Shortage of the sample and control difficulties of the placebo effect.
Clinical relevance: Questionable in more than half of the patients studied. |
---|---|
ISSN: | 0165-0327 1573-2517 |
DOI: | 10.1016/S0165-0327(00)00223-8 |